Skip to Content

WPI 2234 (Tetracycline Hydrochloride 250 mg)

Pill with imprint WPI 2234 is Orange & Yellow, Capsule-shape and has been identified as Tetracycline Hydrochloride 250 mg. It is supplied by Watson Pharmaceuticals, Inc..

Tetracycline is used in the treatment of bacterial infection; acne; bladder infection; bronchitis; nongonococcal urethritis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2234

Tetracycline hydrochloride 250 mg WPI 2234

Tetracycline Hydrochloride

Imprint:
WPI 2234
Strength:
250 mg
Color:
Orange & Yellow
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2234
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide